Development and Validation of Stability-Indicating High Performance Liquid Chromatographic (HPLC) and DD₁-Spectrophotometric Assays for Etodolac in Bulk Form and in Pharmaceutical Dosage Form

REFERENCES

• Balfour , J.A. ; Buckley , M.M.-T. Etodolac . A reappraisal of its pharmacology and therapeutic use in rheumatoid diseases and pain states. Drugs. 1991 , 42 , 274 – 299 .
   Google Scholar
• Sano , T. ; Ozaki , K. ; Kodama , Y. ; Matsuura , T. ; Narama , I. Paradoxical effects of a selective cyclooxygenase-2-inhibitor, Etodolac, on proliferative changes of forestomach in alloxan-induced diabetic rats . Exptl. Tox. Pathol. 2009 , 61 , 371 – 380 .
   Google Scholar
• De Souza Thiago , L. ; Sobral da Costa , L. ; Vieira Lopes , D. ; Borojevic , R. Racemic Etodolac is cytotoxic and cytostatic for B-cell precursor acute lymphoblastic leukemia cells . Biomed. Pharmacother. 2009 , 63 , 548 – 551 .
   Google Scholar
• Magari , H. ; Yanaoka , K. ; Niwa , T. ; Deguchi , H. ; Kanno , T. ; Shiraki , T. ; Mukoubayashi , C. ; Inoue , I. ; Maekita , T. ; Iguchi , M. ; Tamai , H. ; Arii , K. ; Oka , M. ; Ichinose , M. A selective cyclooxygenase-2 inhibitor, Etodolac, suppresses stomach carcinogenesis after eradication therapy of Helicobacter pylori in mongolian gerbils with intestinal metaplasia . Gastroenterol. 2008 , 134 ( Supplement 1 ), A-630 – A-631 .
   Google Scholar
• Okamoto , A. ; Shirakawa , T. ; Bito , T. ; Shigemura , K. ; Hamada , K. ; Gotoh , A. ; Fujisawa , M. ; Kawabata , M. Etodolac, a selective cyclooxygenase-2 inhibitor, induces upregulation of E-cadherin and has antitumor effect on human bladder cancer cells In Vitro and In Vivo . Urology 2008 , 71 , 156 – 160 .
   PubMed Web of Science ®Google Scholar
• Miyamoto , H. ; Onuma , H. ; Shigematsu , H. ; Suzuki , S. ; Sekashita , H. The effect of etodolac on experimental temporomandibular joint osteoarithritis in dogs. J. Cranio-Maxillofacial Surg. 2007, 35, 358–363.
   Google Scholar
• Behari , J. ; Zeng , G. ; Otruba , W. ; Thompson , M.D. ; Muller , P. ; Micsenyi , A. ; Sekhon , S.S. ; Leoni , L. ; Monga , S.P.S. R-Etodolac decreases β-catenin levels along with survival and proliferation of hepatoma cells . J. Hepatol. 2007 , 46 , 849 – 857 .
   PubMed Web of Science ®Google Scholar
• Dung , P.T. ; Ko , M.Y. ; Choi , H.J. ; Sin , K.S. ; Kim , K.H. Determination of enantiomeric impurity of etodolac by capillary electrophoresis using (2-hydroxy)-ß-cyclodextrin . Archives Pharma. Res. 2008 , 31 , 1218 – 1223 .
   Google Scholar
• Jin , Y.-X. ; Tang , Y.-H. ; Zeng , S. Analysis of flurbiprofen, ketoprofen and etodolac enantiomers by pre-column derivatization RP-HPLC and application to drug–protein binding in human plasma . J. Pharmaceut. Biomed. Anal. 2008 , 46 , 953 – 958 .
   PubMed Web of Science ®Google Scholar
• Cosyns , L. ; Spain , M. ; Kraml , M. Senstive high-performance liquid chromatographic method for the determination of etodolac in serum . J. Pharmaceut. Sci. 1983 , 72 , 275 – 277 .
   Google Scholar
• Lee , H.-S. ; Kang , I.M. ; Lee , H.-W. ; Seo , J.-H. ; Ryu , J.-H. ; Choi , S.-J. ; Lee , M.-J. ; Jeong , S.-Y. ; Cho , Y.-W. ; Lee , K.-T. Development and validation of a high performance liquid chromatography–tandem mass spectrometry for the determination of etodolac in human plasma . J. Chromatogr. B 2008 , 863 , 158 – 162 .
   Google Scholar
• Garcia , J.B. ; Lúcia , M. ; Saraiva , M.F.S. ; Lima , J.L.F.C. Determination and antioxidant activity evaluation of etodolac and an anti-inflammatory drug by sequential injection analysis . Analy. Chim. Acta 2006 , 573–574 , 371 – 375 .
   Google Scholar
• Ficarra , R. ; Ficarra , P. ; Calabro , M.L. ; Costantino , D. Quantitative high-performance liquid chromatographic determination of etodolac in pharmaceutical formulations . IL Farmaco. 1991 , 46 , 403 – 407 .
   Google Scholar
• International conference on Harmonization (ICH) of Stability Testing of New Drug substances and products (QIAR2) IFPMA, Geneva, 2003 .
   Google Scholar
• Moffat , A.C. ; Osselten , M.D. ; Widdop , B. Clarke's Analysis of Drugs and poisons in pharmaceuticals, Body Fluids and Post mortem Material, , 3rd ed. ; Pharmaceuticals Press : London , 2004 ; 701 .
   Google Scholar
• Lee , Y.J. ; Padula , J. ; Lee , H.K. Kinetics and mechanisms of Etodolac degradation in aqueous solutions . J. Pharm. Sci. 1988 , 77 , 81 – 86 .
   PubMed Web of Science ®Google Scholar
• Salinas , F. ; Berzas Nevado , J.J. ; Eopinosa Mansilla , A. A new spectrophotometric method for quantitative multicomponent analysis resolution of mixtures of salicylic and salicyluric acids . Talanta. 1990 , 37 , 347 – 351 .
   PubMed Web of Science ®Google Scholar
• Clark , E.G.C. Clarke's Isolation and Identification of Drugs in pharmaceuticals” Body Fluids and Post-Mortem Materials, , 2nd Ed. ; The Pharmaceutical Press : London , 1986 .
   Google Scholar
• Hinchen , J.D. Practical Statistics for Chemical Research, , 1st ed. ; London , 1969 .
   Google Scholar